ReviewFrontiers in neurology2026
Exercise modulation of BDNF/TrkB signaling in Parkinson's disease: an evidence-calibrated review of neuroprotective mechanisms, biomarker limitations, and translational gaps.
Review in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by dopaminergic neuronal loss and persistent motor and non-motor impairment. Exercise has emerged as a promising and helpful adjunctive strategy for PD because it improves functional outcomes and may engage biological processes related to neuroprotection and neuroplasticity. Among these mechanisms, brain-derived neurotrophic factor (BDNF) and tropomyosin receptor kinase B (TrkB) signaling have received increasing attention. This review summarizes pathological alterations of BDNF/TrkB signaling in PD and evaluates how exercise may influence this system to support neuronal survival, synaptic plasticity, and microenvironmental homeostasis. Evidence from animal studies suggests that the phosphoinositide 3-kinase/Akt (PI3K/Akt) and mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) pathways are mainly supported by preclinical PD exercise studies that assessed dopaminergic preservation, downstream pathway activation, and behavioral recovery. In contrast, phospholipase Cγ (PLCγ)-related signaling, TrkB isoform-specific regulation, astrocyte-dependent mechanisms, and trophic trafficking remain less clearly defined. This review also emphasizes key translational gaps, including peripheral BDNF biomarker limitations, the mismatch between human biomarker studies and animal mechanistic studies, and the need to match exercise prescriptions with specific BDNF/TrkB-related mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.